The mucormycosis and Stroke: the learning curve during the second COVID-19 pandemic

Background The Angio-invasive Rhino-orbito-cerebral mucormycosis (ROCM) producing strokes is a less explored entity. Our hospital, a stroke-ready one, had an opportunity to manage mucormycosis when it was identified as the nodal center for mucormycosis management. We are sharing our experiences and mistakes in managing the cerebrovascular manifestations of ROCM.Methods We conducted a prospective observational study during the second wave of the COVID-19 pandemic from 1st May 2021 to 30th September 2021, where consecutive patients aged more than 18 years with microbiologically confirmed cases of ROCM were included.

Source: Journal of Stroke and Cerebrovascular Diseases - October 12, 2022 Category: Neurology Authors: Dileep Ramachandran, Aravind R, Praveen Panicker, Jayaprabha S, MC Sathyabhama, Abhilash Nair, Raj S. Chandran, Simon George, Chintha S, Thomas Iype Source Type: research